ACT-AD Part of 4th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
The 4th Clinical Trials on Alzheimer’s Disease (CTAD) Conference took place from November 3 to November 5, 2011. At this conference, Alzheimer’s leaders involved in clinical trials from around the world gathered to discuss the full spectrum of Alzheimer’s disease from an asymptomatic stage through dementia, the development of the next generation of Alzheimer’s disease treatments and learn to harmonize various neuroimaging techniques and their analyses. ACT-AD had a presence at this conference. On November 4, ACT-AD sponsors an informal meeting of leading Alzheimer’s experts attending the conference from the U.S., Europe and Asia. The meeting provides an opportunity for these experts to share their insights into how the development and evaluation of novel AD therapies could be improved.